Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke

Intravenous Alteplase in Ischemic Stroke Patients not Fully Adhering to the Current Drug License in Central and Eastern Europe

(2013) Michal Karlinski et al.   International Journal of Stroke

Results of Intravenous Thrombolysis Within 4.5 to 6 Hours and Updated Results Within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR)

(2013) Niaz Ahmed   JAMA Neurology

Safety and Outcomes following Thrombolytic Treatment in Stroke Patients Who Had Received Prior Treatment with Anticoagulants

(2012) María-Consuelo Matute et al.   CEREBROVASCULAR DISEASES

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

(2012) Joanna M Wardlaw et al.   LANCET

No Increased Risk of Symptomatic Intracerebral Hemorrhage After Thrombolysis in Patients With European Cooperative Acute Stroke Study (ECASS) Exclusion Criteria

(2012) Carolyn A. Cronin et al.   STROKE

Off-Label Thrombolysis for Acute Ischemic Stroke: Rate, Clinical Outcome and Safety Are Influenced by the Definition of ‘Minor Stroke’

(2011) L. Breuer et al.   CEREBROVASCULAR DISEASES

Off-label intravenous thrombolysis in acute stroke

(2011) M. Guillan et al.   EUROPEAN JOURNAL OF NEUROLOGY

Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis

(2011) Raymond C.S. Seet et al.   STROKE

Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke

(2010) Shyam Prabhakaran   ARCHIVES OF NEUROLOGY

Intravenous thrombolysis for acute stroke in patients with cancer

(2010) I. Casado-Naranjo et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Risk of Thrombolytic Therapy for Acute Ischemic Stroke in Patients With Current Malignancy

(2010) Shihab Masrur et al.   Journal of Stroke & Cerebrovascular Diseases

Off-Label Thrombolysis Is Not Associated With Poor Outcome in Patients With Stroke

(2010) Atte Meretoja et al.   STROKE

Early profiles of clinical evolution after intravenous thrombolysis in an unselected stroke population

(2009) M G Delgado et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Pre–Tissue Plasminogen Activator Blood Pressure Levels and Risk of Symptomatic Intracerebral Hemorrhage

(2009) Georgios Tsivgoulis et al.   STROKE

Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator

(2009) Gregory J. del Zoppo et al.   STROKE

Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study

(2008) Nils Wahlgren et al.   LANCET

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of Characteristics of Blood Pressure Profiles and Stroke Outcomes in the ECASS-II Trial

(2007) Mei Yong et al.   STROKE